Eye implant aims to reduce injections for blinding eye disease

NCT ID NCT05381948

Completed Disease control Sponsor: EyePoint Pharmaceuticals, Inc. Source: ClinicalTrials.gov ↗

Summary

This study tested a new, long-acting eye implant called EYP-1901 for people with wet age-related macular degeneration (AMD), a leading cause of vision loss. The goal was to see if the implant, which slowly releases medicine, could work as well as or better than the standard treatment of frequent eye injections. Researchers compared the implant at two different doses to the standard aflibercept injections over 56 weeks in 161 participants.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

EyePoint Investigative Site

Phoenix, Arizona, 85053, United States
EyePoint Investigative Site

Springdale, Arkansas, 72762, United States
EyePoint Investigative Site

Beverly Hills, California, 90211, United States
EyePoint Investigative Site

Campbell, California, 95008, United States
EyePoint Investigative Site

Encino, California, 91436, United States
EyePoint Investigative Site

Fullerton, California, 92835, United States
EyePoint Investigative Site

Glendale, California, 91203, United States
EyePoint Investigative Site

Huntington Beach, California, 92647, United States
EyePoint Investigative Site

Irvine, California, 92697, United States
EyePoint Investigative Site

Pasadena, California, 91107, United States
EyePoint Investigative Site

Poway, California, 92064, United States
EyePoint Investigative Site

Redlands, California, 92373, United States
EyePoint Investigative Site

Sacramento, California, 95825, United States
EyePoint Investigative Site

Walnut Creek, California, 94598, United States
EyePoint Investigative Site

Lakewood, Colorado, 80228, United States
EyePoint Investigative Site

Clearwater, Florida, 33761, United States
EyePoint Investigative Site

Coral Springs, Florida, 33067, United States
EyePoint Investigative Site

Lakeland, Florida, 33805, United States
EyePoint Investigative Site

Melbourne, Florida, 32901, United States
EyePoint Investigative Site

Miami, Florida, 33143, United States
EyePoint Investigative Site

Pensacola, Florida, 32503, United States
EyePoint Investigative Site

Sarasota, Florida, 34239, United States
EyePoint Investigative Site

St. Petersburg, Florida, 33711, United States
EyePoint Investigative Site

Tampa, Florida, 33609, United States
EyePoint Investigative Site

Winter Haven, Florida, 33880, United States
EyePoint Investigative Site

Marietta, Georgia, 30060, United States
EyePoint Investigative Site

‘Aiea, Hawaii, 96701, United States
EyePoint Investigative Site

Chicago, Illinois, 60616, United States
EyePoint Investigative Site

Lemont, Illinois, 60439, United States
EyePoint Investigative Site

Carmel, Indiana, 46290, United States
EyePoint Investigative Site

West Des Moines, Iowa, 50266, United States
EyePoint Investigative Site

Baltimore, Maryland, 21209, United States
EyePoint Investigative Site

Hagerstown, Maryland, 21740, United States
EyePoint Investigative Site

Owings Mills, Maryland, 21117, United States
EyePoint Investigative Site

Boston, Massachusetts, 02114, United States
EyePoint Investigative Site

Springfield, Massachusetts, 01107, United States
EyePoint Investigative Site

Grand Rapids, Michigan, 49446, United States
EyePoint Investigative Site

Saint Louis, Michigan, 55416, United States
EyePoint Investigative Site

St Louis, Missouri, 63128, United States
EyePoint Investigative Site

Reno, Nevada, 89502, United States
EyePoint Investigative Site

Teaneck, New Jersey, 07666, United States
EyePoint Investigative Site

Great Neck, New York, 11021, United States
EyePoint Investigative Site

Hauppauge, New York, 11788, United States
EyePoint Investigative Site

Liverpool, New York, 13088, United States
EyePoint Investigative Site

Shirley, New York, 11967, United States
EyePoint Investigative Site

Asheville, North Carolina, 28803, United States
EyePoint Investigative Site

Wake Forest, North Carolina, 27587, United States
EyePoint Investigative Site

Eugene, Oregon, 97401, United States
EyePoint Investigative Site

Portland, Oregon, 97239, United States
EyePoint Investigative Site

Springfield, Oregon, 97488, United States
EyePoint Investigative Site

Charleston, South Carolina, 29414, United States
EyePoint Investigative Site

West Columbia, South Carolina, 29169, United States
EyePoint Investigative Site

Germantown, Tennessee, 38138, United States
EyePoint Investigative Site

Nashville, Tennessee, 37203, United States
EyePoint Investigative Site

Abilene, Texas, 79606, United States
EyePoint Investigative Site

Dallas, Texas, 75231, United States
EyePoint Investigative Site

McAllen, Texas, 78503, United States
EyePoint Investigative Site

Plano, Texas, 75075, United States
EyePoint Investigative Site

San Antonio, Texas, 78240, United States
EyePoint Investigative Site

The Woodlands, Texas, 77384, United States
EyePoint Investigative Site

Salt Lake City, Utah, 84107, United States
EyePoint Investigative Site

Fairfax, Virginia, 22031, United States
EyePoint Investigative Site

Lynchburg, Virginia, 24502, United States
EyePoint Investigative Site

Warrenton, Virginia, 20186, United States
EyePoint Investigative Site

Silverdale, Washington, 98383, United States
EyePoint Investigative Sites

Austin, Texas, 78750, United States
EyePoint Investigative Sites

Houston, Texas, 77025, United States

Conditions

Explore the condition pages connected to this study.

WET AGE-RELATED MACULAR DEGENERATION